TelyRx Holdings Inc. experienced a significant uptick in its stock price during yesterday's trading session.
TelyRx Holdings Inc. saw its stock price rise by an impressive 8.75% yesterday, closing at CA$2.61. This surge comes as the company continues to navigate its recent transition and establish its presence in the market.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$66.48M
52W high
$4.25
52W low
$2.00
1W change
-1.96%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 140.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+140.0% Upside
Current Price
C$2.50
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
99.3%
Annualized
90-Day Vol
95.6%
Annualized
Trend (90d)
+17.1%
Annualized drift
90d Mean
C$2.66
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.55 | C$1.81 โ C$3.59 |
| 60 trading days | C$2.60 | C$1.60 โ C$4.23 |
| 90 trading days | C$2.66 | C$1.47 โ C$4.81 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may find TelyRx's recent performance encouraging, particularly as it builds on its recent operational milestones and financial results.
TelyRx stock up 8.75% yesterday
With a market cap of CA$63.79 million, TelyRx's stock price increase signals a positive reception from investors, albeit amidst a backdrop of financial challenges.
Bull case
The recent rise in TelyRx's stock price shows that investors are gaining confidence in the company. This boost could be linked to the positive operational updates and strategic steps TelyRx has taken recently.
Bear case
Even with this positive momentum, TelyRx's ongoing net losses might worry investors about its long-term profitability and financial stability.
Advertisement
Recent Performance Highlights
TelyRx's stock price increased by 8.75% yesterday, closing at CA$2.61. This uptick is a positive sign for investors, especially as the company recently completed its qualifying transaction and began trading on the TSX under the ticker symbol 'TELY'.
Financial Outlook
While TelyRx's recent performance is encouraging, investors should remain cautious. The company reported a net loss of CA$4.7 million in its latest quarterly results, raising questions about its long-term profitability. Ongoing monitoring of TelyRx's financial health will be crucial for investors considering a stake in the company. For more details, check out the TelyRx Holdings Inc. stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
